Published in Nat Rev Endocrinol on April 03, 2012
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
Molecular and cellular aspects of calcific aortic valve disease. Circ Res (2013) 1.12
Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals. Circ Res (2015) 0.99
Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr (2012) 0.96
Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clin Interv Aging (2013) 0.89
Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification. Stem Cells Dev (2014) 0.88
Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int (2015) 0.87
Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model. Atherosclerosis (2014) 0.87
Ankle-brachial index and bone turnover in patients on dialysis. J Am Soc Nephrol (2014) 0.87
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? Osteoporos Int (2015) 0.86
From "Kidneys Govern Bones" to Chronic Kidney Disease, Diabetes Mellitus, and Metabolic Bone Disorder: A Crosstalk between Traditional Chinese Medicine and Modern Science. Evid Based Complement Alternat Med (2016) 0.84
The Key Role of the Blood Supply to Bone. Bone Res (2013) 0.83
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS). J Bone Miner Res (2016) 0.82
Assessment of bone vascularization and its role in bone remodeling. Bonekey Rep (2015) 0.81
QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study. J Bone Miner Res (2015) 0.80
Chronic kidney disease and the skeleton. Bone Res (2014) 0.79
Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. Am J Clin Nutr (2014) 0.79
Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients. Clin Kidney J (2015) 0.77
Small vessel disease/white matter disease of the brain and its association with osteoporosis. J Clin Med Res (2015) 0.77
Cinacalcet ameliorates aortic calcification in uremic rats via suppression of endothelial-to-mesenchymal transition. Acta Pharmacol Sin (2016) 0.77
Abdominal Aortic Calcification Identified on Lateral Spine Images From Bone Densitometers Are a Marker of Generalized Atherosclerosis in Elderly Women. Arterioscler Thromb Vasc Biol (2015) 0.76
Elevated PTH induces endothelial-to-chondrogenic transition in aortic endothelial cells. Am J Physiol Renal Physiol (2016) 0.76
The association of calcium supplementation and incident cardiovascular events in the Multi-ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis (2016) 0.76
Bone Microarchitecture in Type 1 Diabetes: It Is Complicated. Curr Osteoporos Rep (2016) 0.76
Arteriosclerosis, bone biology, and calciotropic hormone signaling: learning the ABCs of disease in the bone-vascular axis. J Am Soc Nephrol (2014) 0.76
Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study. Osteoporos Int (2014) 0.76
Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2. Oncotarget (2016) 0.76
Mechanisms of Vascular Calcification: The Pivotal Role of Pyruvate Dehydrogenase Kinase 4. Endocrinol Metab (Seoul) (2016) 0.76
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int (2013) 0.76
Vascular calcification, bone and mineral metabolism after kidney transplantation. World J Transplant (2015) 0.75
"Osteotropic" Wnt/LRP Signals: High-Wire Artists in a Balancing Act Regulating Aortic Structure and Function. Arterioscler Thromb Vasc Biol (2017) 0.75
Increased Aortic Calcification Is Associated With Arterial Stiffness Progression in Multiethnic Middle-Aged Men. Hypertension (2016) 0.75
Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos Int (2015) 0.75
Impact of radiographic vertebral fractures on inpatient healthcare utilization in older women. Bone (2016) 0.75
Bone Mineral Density and Progression of Subclinical Atherosclerosis in African-Americans With Type 2 Diabetes. J Clin Endocrinol Metab (2016) 0.75
Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications. Arterioscler Thromb Vasc Biol (2016) 0.75
Chronic kidney disease: the "perfect storm" of cardiometabolic risk illuminates genetic diathesis in cardiovascular disease. J Am Coll Cardiol (2013) 0.75
Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases. BMC Cardiovasc Disord (2016) 0.75
MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23. Iran J Basic Med Sci (2016) 0.75
AMPKα1: SUMO Wrestling Runx2 as a Strategy to Inhibit Arteriosclerotic Calcification. Circ Res (2016) 0.75
The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int (2017) 0.75
Commonalities Between Vasculature and Bone: An Osseocentric View of Arteriosclerosis. Circulation (2017) 0.75
Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification. Sci Rep (2017) 0.75
Nutrition in Cardioskeletal Health. Adv Nutr (2016) 0.75
Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft. J Vasc Surg (2016) 0.75
Subclinical Indication of Linkage Between Markers of Skeletal and Cardiovascular Properties. Bone Res (2013) 0.75
Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone. J Endocrinol (2017) 0.75
New Aspects of Vascular Calcification: Histone Deacetylases and Beyond. J Korean Med Sci (2017) 0.75
Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice. J Cell Biochem (2017) 0.75
Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin. Osteoporos Int (2017) 0.75
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol (2005) 5.76
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell (2010) 4.99
Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59
Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest (1993) 4.54
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab (2006) 4.33
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A (2002) 4.22
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med (2000) 4.13
Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol (2007) 3.85
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 3.77
Vascular calcification: pathobiology of a multifaceted disease. Circulation (2008) 3.64
Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet (2000) 3.64
Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res (2009) 3.53
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51
Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res (2001) 3.50
BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res (2003) 3.32
Ageing of the conduit arteries. J Pathol (2007) 3.23
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol (2004) 3.22
Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol (2007) 3.13
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest (2005) 3.00
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol (2006) 2.95
Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet (2008) 2.82
Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol (1997) 2.80
A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science (1995) 2.78
MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem (2003) 2.78
Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int (2011) 2.77
End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol (2007) 2.73
Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69
Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol (2000) 2.66
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A (2008) 2.65
The arterial Windkessel. Med Biol Eng Comput (2008) 2.62
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61
Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab (2006) 2.58
Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development (2002) 2.57
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med (2010) 2.55
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem (2008) 2.55
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med (2009) 2.54
Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation (2008) 2.39
Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation (2002) 2.39
The case against calcium-based phosphate binders. Clin J Am Soc Nephrol (2006) 2.38
CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest (2010) 2.38
1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation (2009) 2.36
Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res (2005) 2.33
Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol (2009) 2.29
Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol (2006) 2.28
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res (2008) 2.23
Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol (2007) 2.22
Regulatory mechanisms in vascular calcification. Nat Rev Cardiol (2010) 2.22
Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res (2008) 2.19
Multilineage potential of cells from the artery wall. Circulation (2003) 2.17
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol (2007) 2.16
Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol (2003) 2.15
Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J (2004) 2.11
Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol (2004) 2.10
Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem (1998) 2.10
Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem (2001) 2.02
Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res (2007) 1.92
Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia (1988) 1.91
Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation (2005) 1.91
Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol (2008) 1.89
Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) (2009) 1.87
Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res (2000) 1.86
Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol (2008) 1.85
Cellular pathology. As based upon physiological and pathological histology. Lecture XVI--Atheromatous affection of arteries. 1858. Nutr Rev (1989) 1.84
Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem (2000) 1.83
BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis (2008) 1.80
Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res (2005) 1.79
Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res (2009) 1.76
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant (2005) 1.76
Bone as an endocrine organ. Trends Endocrinol Metab (2009) 1.75
Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol (2006) 1.75
Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol (2005) 1.75
Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res (2010) 1.75
Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun (1998) 1.74
The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A (2006) 1.73
Bone and the hematopoietic niche: a tale of two stem cells. Blood (2011) 1.73
Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis (2007) 1.72
Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol (2005) 1.70
Bone Gla protein increases HIF-1alpha-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol (2011) 1.69
Fetuin-A regulation of calcified matrix metabolism. Circ Res (2011) 1.69
Monocyte/macrophage regulation of vascular calcification in vitro. Circulation (2002) 1.67
FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23. Bone (2007) 1.66
Regulation of skeletogenic differentiation in cranial dermal bone. Development (2007) 1.65
Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation (2003) 1.65
Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology (1999) 1.64
Arterial aging: pathophysiological principles. Vasc Med (2007) 1.63
PDGF and vessel maturation. Recent Results Cancer Res (2010) 1.62
Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development (2003) 4.63
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest (2005) 3.00
MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem (2003) 2.78
Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol (2006) 2.28
Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol (2007) 2.22
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab (2004) 2.14
An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res (2006) 1.88
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant (2005) 1.76
Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension (2010) 1.61
Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters. J Biol Chem (2003) 1.50
Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem (2008) 1.43
Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem (2003) 1.40
Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci (2007) 1.37
Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res (2005) 1.34
Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex. J Biol Chem (2002) 1.30
The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res (2011) 1.29
Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res (2010) 1.29
Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J Biol Chem (2002) 1.14
MINT, the Msx2 interacting nuclear matrix target, enhances Runx2-dependent activation of the osteocalcin fibroblast growth factor response element. J Biol Chem (2004) 1.13
Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol (2013) 1.08
De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem (2010) 1.02
TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. Endocrinology (2012) 0.99
Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness. J Am Soc Echocardiogr (2008) 0.97
Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter. Biochem J (2005) 0.97
Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol (2011) 0.96
Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler Thromb Vasc Biol (2005) 0.96
Oxidation, inflammation, and aortic valve calcification peroxide paves an osteogenic path. J Am Coll Cardiol (2008) 0.90
Vascular calcification: it's all the RAGE! Arterioscler Thromb Vasc Biol (2011) 0.89
Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligand. Maturitas (2009) 0.88
Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section. Am J Pathol (2006) 0.87
Transcriptional regulation of SM22alpha by Wnt3a: convergence with TGFbeta(1)/Smad signaling at a novel regulatory element. J Mol Cell Cardiol (2009) 0.87
Calciotropic hormones and arterial physiology: "D"-lightful insights. J Am Soc Nephrol (2007) 0.86
Runx2 trans-activation mediated by the MSX2-interacting nuclear target requires homeodomain interacting protein kinase-3. Mol Endocrinol (2010) 0.86
Vascular calcification in ESRD: Another cloud appears in the perfect storm--but highlights a silver lining? Kidney Int (2004) 0.83
Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands. J Biol Chem (2009) 0.82
Angiogenesis and marrow stromal cell fates: roles in bone strength. Osteoporos Int (2003) 0.82
Imaging aortic matrix metabolism: mirabile visu! Circulation (2007) 0.82
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus. J Steroid Biochem Mol Biol (2008) 0.81
Wnt signaling in cardiovascular disease: opportunities and challenges. Curr Opin Lipidol (2017) 0.81
Mitochondrial ROS deficiency and diabetic complications: AMP[K]-lifying the adaptation to hyperglycemia. J Clin Invest (2013) 0.80
The pharmacological management of osteoporosis. Mo Med (2011) 0.78
Improving mass measurement of coronary artery calcification using threshold correction and thin collimation in multi-detector row computed tomography: in vitro experiment. Acad Radiol (2003) 0.77
Chronic kidney disease: the "perfect storm" of cardiometabolic risk illuminates genetic diathesis in cardiovascular disease. J Am Coll Cardiol (2013) 0.75
Diabetic foot osteomyelitis: bone markers and treatment outcomes. Diabetes Res Clin Pract (2012) 0.75